CytoSorbents Corporation (CTSO)

[alexander77]

Pipeline opportunities:

IMO when they have the CE mark approval, they will be able to use these revenues partially for a) trials in the US and b) for clinical trials for the rest of their pipeline which is quite impressive:

1) betasorb: improvement of hemodialysis in end-stage renal disease
2) cytosorb (other than sepsis treatment): cardiopulmonary bypass + organ transplant + influenza
3) CST 101: drug overdose + chemical exposure or intoxication
4) CST 201: chemotherapy removal
5) CST 301: removal of myoglobin from blood caused by muscle breakdown and trauma

http://www.cytosorbents.com/pdf/CytoSorbents_Investor_Executive_Summary_September_2009_Final_090309.pdf
page 3